rs10497192
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001111067.4(ACVR1):c.-8+3197G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.554 in 151,968 control chromosomes in the GnomAD database, including 28,338 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.55   (  28338   hom.,  cov: 32) 
Consequence
 ACVR1
NM_001111067.4 intron
NM_001111067.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -2.27  
Publications
11 publications found 
Genes affected
 ACVR1  (HGNC:171):  (activin A receptor type 1) Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008] 
ACVR1 Gene-Disease associations (from GenCC):
- fibrodysplasia ossificans progressivaInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, ClinGen, Orphanet
 - congenital heart diseaseInheritance: AD Classification: LIMITED Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.723  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.554  AC: 84138AN: 151848Hom.:  28336  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
84138
AN: 
151848
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.554  AC: 84143AN: 151968Hom.:  28338  Cov.: 32 AF XY:  0.557  AC XY: 41411AN XY: 74284 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
84143
AN: 
151968
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
41411
AN XY: 
74284
show subpopulations 
African (AFR) 
 AF: 
AC: 
6183
AN: 
41422
American (AMR) 
 AF: 
AC: 
10781
AN: 
15274
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2580
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
2151
AN: 
5166
South Asian (SAS) 
 AF: 
AC: 
3476
AN: 
4812
European-Finnish (FIN) 
 AF: 
AC: 
7513
AN: 
10542
Middle Eastern (MID) 
 AF: 
AC: 
203
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
49475
AN: 
67970
Other (OTH) 
 AF: 
AC: 
1241
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 1442 
 2885 
 4327 
 5770 
 7212 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 688 
 1376 
 2064 
 2752 
 3440 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1867
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.